1. Pink Sheet
  2. >>Geography

Japan Readies One-Off Price Cuts For Big Sellers

Entresto Slashed By 15%

 
• By Lisa Takagi

Japanese regulatory authorities have announced a set of additional reimbursement price cuts for selected products in August, under which Novartis’s heart failure drug Entresto will see its price slashed by 15%. A batch of other newly approved drugs has also been priced.

The market expansion repricing was applied to five products.
market expansion repricing applied to five products • Source: Shutterstock

Following the latest round of of annual drug reimbursement price cuts announced in March and implemented in April, Japanese regulatory authorities have now announced additional extraordinary price revisions for five products, effective 1 August.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Asia